Arista Networks Available For Sale Securities Debt Securities Current increased by 8.9% to $9.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.7%, from $6.30B to $9.56B. Over 5 years (FY 2020 to FY 2025), Available For Sale Securities Debt Securities Current shows an upward trend with a 34.7% CAGR.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39B | $2.76B | $2.79B | $2.79B | $2.41B | $2.26B | $2.35B | $2.37B | $2.48B | $2.71B | $3.07B | $3.36B | $3.84B | $4.25B | $5.54B | $6.30B | $6.62B | $7.78B | $8.78B | $9.56B |
| QoQ Change | — | +15.4% | +1.2% | +0.0% | -13.6% | -6.0% | +3.9% | +1.0% | +4.4% | +9.2% | +13.4% | +9.4% | +14.5% | +10.6% | +30.3% | +13.8% | +5.0% | +17.5% | +12.8% | +8.9% |
| YoY Change | — | — | — | — | +0.9% | -17.8% | -15.6% | -14.8% | +2.9% | +19.6% | +30.5% | +41.4% | +55.1% | +57.1% | +80.5% | +87.8% | +72.1% | +82.9% | +58.4% | +51.7% |